secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAPTYSBIO, INC (ANAB)
CIK:        0001370053
Form:       8-K
Filed at:   2025-03-24T23:59:59+00:00
Accession:  0001370053-25-000028
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AnaptysBio authorizes up to $75M stock repurchase plan
------------------------------------------------------

- Board authorized $75M buyback of outstanding common stock.
- Company holds >$420M cash as of Dec 2024; expects $75M GSK milestone in 2025/2026.
- Reiterates cash runway through year-end 2027, excluding potential GSK royalties.
- Repurchases via open market under Rule 10b5-1; plan expires Dec 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1370053/000137005325000028/0001370053-25-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1370053/000137005325000028/anab-20250324.htm
  HTML page:      https://secwatch.observer/filing/0001370053-25-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer